BioMarin to Participate in Four Upcoming Investor Conferences in March

SAN RAFAEL, Calif., Feb. 24, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced management will participate in four upcoming investor conferences in March.

TD Cowen 46th Annual Health Care Conference (Boston, MA)

Leerink 2026 Global Healthcare Conference (Miami, FL)

Jefferies 2026 Biotech on the Bay Summit (Miami, FL)

Barclays 28 th Annual Global Healthcare Conference (Miami, FL)

The fireside chats will be webcast live and can be accessed by visiting BioMarin's website at https://investors.biomarin.com/. A webcast replay will be available through the Company's website for a limited time following the conferences.

About BioMarin

BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with multiple commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com.

Contacts:

Investors

Media

Traci McCarty

Marni Kottle

BioMarin Pharmaceutical Inc.

(415) 455-7558

(650) 374-2803

SOURCE BioMarin Pharmaceutical Inc.